In Vitro Analysis of the Effect of In-Line 1.2 Micron Filters on Two Formulations of Propofol (2,6-Diisopropyl Phenol)

References

1. 1.↵
   1. McKeage K.,
   2. Perry C. M.

   Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 2003, 17 (4), 235–272.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Momot K. I.,
   2. Kuchel P. W.,
   3. Chapman B. E.,
   4. Deo P.,
   5. Whittaker D.

   NMR study of the association of propofol with nonionic surfactants. Langmuir 2003, 19 (6), 2088–2095.

   OpenUrl
3. 3.↵
   1. Thompson K. A.,
   2. Goodale D. B.

   The recent development of propofol (Diprivan). Intensive Care Med. 2000, 26 (Suppl. 4), S400–S404.

   OpenUrlPubMed
4. 4.↵
   1. Kanto J.,
   2. Gepts E.

   Pharmacokinetic implications for the clinical use of propofol. Clin. Pharmacokinet. 1989, 17 (5), 308–326.

   OpenUrlPubMedWeb of Science
5. 5.↵
   1. Gabathuler R.

   Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol. Dis. 2010, 37 (1), 48–57.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Fulton B.,
   2. Sorkin E. M.

   Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995, 50 (4), 636–657.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Wong G. L. S.,
   2. Morton N. S.

   Total intravenous anesthesia (TIVA) in pediatric cardiac anesthesia. Paediatr. Anaesthes. 2011, 21 (5), 560–566.

   OpenUrl
8. 8.↵
   1. Jack T.,
   2. Brent B. E.,
   3. Boehne M.,
   4. Müller M.,
   5. Sewald K.,
   6. Braun A.,
   7. Wessel A.,
   8. Sasse M.

   Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit. Intensive Care Med. 2010, 36 (4), 707–711.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Jack T.,
   2. Boehne M.,
   3. Brent B. E.,
   4. Hoy L.,
   5. Köditz H.,
   6. Wessel A.,
   7. Sasse M.

   In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med. 2012, 38 (6), 1008–1016.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Ball P. A.

    Intravenous in-line filters: filtering the evidence. Curr. Opin. Clin. Nutr. Metab. Care 2003, 6 (3), 319–325.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Han J.,
    2. Davis S. S.,
    3. Washington C.

    Physical properties and stability of two emulsion formulations of propofol. Int. J. Pharm. 2001, 215 (1–2), 207–220.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Driscoll D. F.,
    2. Giampietro K.,
    3. Wichelhaus D. P.,
    4. Peterss H.,
    5. Nehne J.,
    6. Niemann W.,
    7. Bistrian B. R.

    Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin. Nutr. 2001, 20 (2), 151–157.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Steger P. J.,
    2. Mühlebach S. F.

    In vitro oxidation of IV lipid emulsions in different all-in-one admixture bags assessed by an iodometric assay and gas-liquid chromatography. Nutrition 1997, 13 (2), 133–140.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Cho J.,
    2. Cho J. C.,
    3. Lee P.,
    4. Lee M.,
    5. Oh E.

    Formulation and evaluation of an alternative triglyceride-free propofol microemulsion. Arch. Pharm. Res. 2010, 33 (9), 1375–1387.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Matthews P.

    Design of Experiments with MINITAB, 1st ed.; ASQ Quality Press: Milwaukee, WI, 2004; p 248.
16. 16.↵
    1. Sokal R. R.,
    2. Rohlf F. J.

    Biometry. Principles and Practice of Statistics in Biological Research, 3rd ed.; W. H. Freeman and Company: New York, 1994.
17. 17.↵
    1. Johnson R. C.,
    2. Young S. K.,
    3. Cotter R.,
    4. Lin L.,
    5. Rowe W. B.

    Medium-chain triglyceride lipid emulsion: metabolism and tissue distribution. Am. J. Clin. Nutr. 1990, 52 (3), 503–508.

    OpenUrl
18. 18.↵
    1. Steger P. J. K.,
    2. Muhlebach S. F.

    Lipid peroxidation of IV lipid emusions in TPN bags: the infuence of tocopherols. Nutrition 1997, 14 (2), 179–185.

    OpenUrl
19. 19.↵
    1. Steger P. J. K.,
    2. Muhlebach S. F.

    Lipid peroxidation of intravenous lipid emulsions and all-in-one admixtures in total parenteral nutrition bags: the influence of trace elements. JPEN J. Parenter. Enteral Nutr. 2000, 24 (1), 37–41.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. O'Grady N. P.,
    2. Alexander M.,
    3. Burns L. A.,
    4. Patchen Dellinger E.,
    5. Garland J.,
    6. Heard S. O.,
    7. Lipsett P. A.,
    8. Masur H.,
    9. Mermel L. A.,
    10. Pearson M. L.,
    11. Raad I. I.,
    12. Randolf A.,
    13. Rupp M. E.,
    14. Saint S.

    ; Healthcare Infection Control Practices Advisory Committee (HICPAC). 2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections. Center for Disease Control and Prevention: Atlanta, GA, 2011; http://www.cdc.gov/hicpac/bsi/bsi-guidelines-2011.html; accessed July 29, 2014.